MyoKardia Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

MyoKardia key operating metrics including Patents Pending (Foreign), environmental, and social and governance score (ESG).

Patents Pending (Foreign)

41.7%

FY, 2018

Patents Pending (US)

66.7%

FY, 2018

Phase I Trials Products

50.0%

FY, 2018

Operating Metrics

Metrics	FY, 2015	FY, 2016	FY, 2017	FY, 2018
Patents Pending (Foreign)	34	30	60	35
Patents Pending (US)	4	3	3	1
Phase I Trials Products	2	2	2	1
Patents (US)	2	3	4	2
Pre-Clinical Phase Products	1		3	3
Phase II Trials Products		1	1	2
Phase III Trials Products				1

40-49 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Source:CSRHub